SandboxAQ's AQBioSim is shortening drug discovery timelines and achieving remarkable success, particularly in neurodegenerative and oncology fields.
In this video, Nadia Harhen, General Manager of AI Simulation at SandboxAQ, sits down with Andrea Bortolato, Director of Drug Discovery on the AQBioSim team at SandboxAQ, to explore the groundbreaking technologies driving the future of pharmaceutical innovation. They discuss how AQBioSim is revolutionizing the drug discovery process through advanced tools like binding affinity prediction, generative AI, and active learning.
Want to learn more about LQMs? Visit: [ Ссылка ]
